In the data set HS-01450 (Library of Integrated Network-Based Cellular Signatures, LINCS), which include microarray data from HCC cell line (HepG2) treated with 265 inhibitors at several doses (Fig. 2A), we found that many inhibitors significantly reduced ZDHHC7 gene expression at various concentrations and most of the inhibitors were CDK inhibitors (dinaciclib, CGP-60474 and BMS-387032) (Fig. 2A). This evidence concerns the gene ZDHHC7 and hepatocellular carcinoma.